Analystreport

Arcus Biosciences, Inc. (NYSE: RCUS) had its price target raised by analysts at Truist from $45.00 to $70.00.

Arcus Biosciences, Inc.  (RCUS) 
Last arcus biosciences, inc. earnings: 3/5 04:10 pm Check Earnings Report